Innovative Eyewear Inc (LUCY) Stock Price & Analysis
Innovative Eyewear Inc (LUCY) fell 6.40% to USD 0.65 as of July 25, 2026 at 04:24 UTC, according to Nexqual real-time market data.
LUCY last closed at USD 0.7; the session ranged USD 0.65–0.69 on volume of 193,335 shares. Market capitalization is $5.60M, with a 52-week range of USD 0.65–2.27 (NCM). Source: Nexqual, July 25, 2026 at 04:24 UTC.
Key Statistics (as of July 25, 2026 at 04:24 UTC)
| Price | USD 0.65 |
|---|---|
| Change | ▼ 6.40% (down) |
| Previous Close | USD 0.7 |
| Open | USD 0.69 |
| Day Range | USD 0.65 – 0.69 |
| 52-Week Range | USD 0.65 – 2.27 |
| Volume | 193,335 shares |
| Market Cap | $5.60M |
| Exchange | NCM |
Technical Analysis (LUCY)
Nexqual's technical model rates LUCY "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 04:24 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 33.56 (neutral) |
| vs SMA50 | Below (USD 0.91) |
| MACD | -0.06 (negative) |
Analyst Ratings (LUCY)
Wall Street analysts rate LUCY "None", per Nexqual as of July 25, 2026 at 04:24 UTC.
| Consensus Rating | None |
|---|---|
| Buy / Hold / Sell | 0 / 1 / 0 |
Earnings (LUCY)
| Next Earnings Date | 2026-08-13 |
|---|---|
| EPS Estimate | USD -0.37 |
| Revenue Estimate | $900,000 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.37 vs est -0.47 ▲ beat |
| 2025-12-31 | USD -0.28 vs est -0.43 ▲ beat |
| 2025-09-30 | USD -0.38 vs est -0.49 ▲ beat |
| 2025-06-30 | USD -0.66 vs est -0.77 ▲ beat |
Source: Nexqual, July 25, 2026 at 04:24 UTC.
Financials & Fundamentals (LUCY)
| Total Revenue | $2.98M |
|---|---|
| Revenue Growth (YoY) | +70.20% |
| Gross Margin | +17.52% |
| Operating Margin | -306.60% |
| Profit Margin | -272.48% |
| ROE | -102.40% |
| Current Ratio | 8.02 |
| Total Cash | $5.68M |
| Total Debt | $0 |
| Free Cash Flow | $-5.31M |
Source: Nexqual, July 25, 2026 at 04:24 UTC.
Financial Health Score (LUCY)
Nexqual rates Innovative Eyewear Inc's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 04:24 UTC.
| Growth | Strong — Revenue +63% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $6M cash, no debt |
| Cash Flow | Weak — FCF negative: -$5M, burning cash |
| Efficiency | Critical — ROE -102%, ROA -64.3% |
Ownership (LUCY)
| Insider Ownership | +7.60% |
|---|---|
| Institutional Ownership | +9.03% |
| Shares Outstanding | 8.60M |
| Float | 5.76M |
| Short % of Float | +0.39% |
Source: Nexqual, July 25, 2026 at 04:24 UTC.
Leadership (LUCY)
Innovative Eyewear Inc is led by Harrison Reed Gross (age 32), Co-Founder, CEO & Director, per Nexqual as of July 25, 2026 at 04:24 UTC.
| Co-Founder, CEO & Director | Harrison Reed Gross (age 32) |
|---|---|
| Co-Founder & CTO | David Eric Cohen (age 52) |
| Chief Financial Officer | Oswald Anthony Gayle (age 65) |
| Chief Operating Officer | Jaoquin Abondano (age 41) |
Major Backers & Investors (LUCY)
Notable institutional backers of Innovative Eyewear Inc include Cetera Investment Advisers, Fidelity, Keybank National Association, according to Nexqual as of July 25, 2026 at 04:24 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Cetera Investment Advisers | 7.81% |
| Fidelity | 0.82% |
| Keybank National Association | 0.23% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Geode Capital | 0.95% |
Source: Nexqual, July 25, 2026 at 04:24 UTC.
From Innovative Eyewear Inc's Latest SEC 10-K Filing (filed 2026-03-25)
Key Strengths & Strategy (as disclosed to the SEC)
- First launched in 2023, the app deploys a powerful and unique Siri and Bixby integration with the Open AI API for ChatGPT, developed internally by the Company.
- With Lucyd Lyte and our Nautica ®  and Eddie Bauer ®  lines (traditional), Reebok ®  (sport) line, and Lucyd Armor (safety) line, we believe we are the first smart-eyewear company with products concurrently in the traditional, sport, and safety eyewear categories.
- While we face competitors in each segment, we believe our focus on mass‑market use cases and familiar eyewear form factors differentiates our approach from certain competitors that emphasize more technology‑heavy devices.   Compliance and Safety Positioning.
Partnerships
- Our partnership with a third-party optical lab in Florida allows us to offer custom lenses and direct prescription fulfillment to our customers quickly and affordably.   Comfort . At just 1.0 - 1.75 ounces, our eyewear has a feather-light fit, suitable for all day vision correction or sun protection (traditional glasses weigh about 1 ounce).
- We have also participated in a partnership with the Miami Rescue Mission to support our local community with eyewear.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AKAN | Akanda Corp. | USD 7.73 | ▼ 4.09% |
| SOBR | SOBR Safe, Inc. | USD 0.6 | ▲ 3.01% |
| VRAX | Virax Biolabs Group Limited | USD 3.19 | ▼ 12.36% |
| FRGT | Freight Technologies, Inc. | USD 3.01 | ▼ 15.45% |
| SKYA | SkyAI, Inc. | USD 1.39 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:24 UTC. This page is informational and not investment advice.